Published trade mark details for 2538409
This information was published on 2025-07-01T10:09:09 for IP Right Registration Published.
| Field | Value |
| (210) | 2538409 (IR 1849231) |
| (220) |
17 Feb 2025
|
| (300) |
EM, 02 Sep 2024, 019073817
|
| (500) |
Aqua blue and blue-grey.;Aqua blue: RGB: red (0), green (171), blue (206); Blue-Grey: RGB: red (55), green (63), blue (67).
Aqua blue and blue-grey. Aqua blue: RGB: red (0), green (171), blue (206); Blue-Grey: RGB: red (55), green (63), blue (67). |
| (511) (510) |
Class 1
Assays and reagents for scientific and research use; diagnostic reagents for scientific use; senolytics. Class 5 Reagents and assays for medical or veterinary use; pharmaceuticals; pharmaceuticals for the treatment and prevention of chronic diseases; pharmaceuticals for the treatment and prevention of age-related disorders and diseases and neurodegenerative disorders and diseases; pharmaceuticals for healthy ageing; pharmaceuticals for the treatment and prevention of disorders and diseases linked to senescent cell accumulation. Class 42 Scientific research and development; scientific research and development in the fields of senolytics, age-related disorders and diseases and neurodegenerative disorders and diseases therapies; services related to scientific research, development and production of pharmaceutical and biopharmaceutical agents and preparations; services in the field of research, development and production of medical, pharmaceutical and biopharmaceutical products; medical- and pharmacological research services; pharmaceutical, biopharmaceutical drug development services; drug discovery services; providing medical and scientific research information in the field of clinical trials. Class 44 Human healthcare services; medical and healthcare services; medical testing for diagnostic or treatment purposes; medical analysis services relating to the treatment of patients; medical testing services relating to the diagnoses and treatment of diseases; consultancy and information services relating to medical, pharmaceutical and biopharmaceutical products; provision of medical treatment for prophylaxis or therapy; medical and healthcare services in the field of personalized medicine; services of personalized medical treatment for prevention of chronic diseases, age-related disorders and diseases and neurodegenerative disorders and diseases; information consultancy and advisory services in relation to the aforesaid. |
| (540) |
|
| (550) | Figurative |
| (730) |
Rockfish Bio AG
|
Find out more about publications on the About page.